» Articles » PMID: 28721267

Amyloid Proteotoxicity Initiates an Inflammatory Response Blocked by Cannabinoids

Overview
Specialty Geriatrics
Date 2017 Jul 20
PMID 28721267
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

The beta amyloid (Aβ) and other aggregating proteins in the brain increase with age and are frequently found within neurons. The mechanistic relationship between intracellular amyloid, aging and neurodegeneration is not, however, well understood. We use a proteotoxicity model based upon the inducible expression of Aβ in a human central nervous system nerve cell line to characterize a distinct form of nerve cell death caused by intracellular Aβ. It is shown that intracellular Aβ initiates a toxic inflammatory response leading to the cell's demise. Aβ induces the expression of multiple proinflammatory genes and an increase in both arachidonic acid and eicosanoids, including prostaglandins that are neuroprotective and leukotrienes that potentiate death. Cannabinoids such as tetrahydrocannabinol stimulate the removal of intraneuronal Aβ, block the inflammatory response, and are protective. Altogether these data show that there is a complex and likely autocatalytic inflammatory response within nerve cells caused by the accumulation of intracellular Aβ, and that this early form of proteotoxicity can be blocked by the activation of cannabinoid receptors.

Citing Articles

Therapeutic assessment of a novel mitochondrial complex I inhibitor in and models of Alzheimer's disease.

Trushin S, Nguyen T, Stojacovic A, Ostroot M, Trey Deason J, Chang S bioRxiv. 2025; .

PMID: 40027647 PMC: 11870434. DOI: 10.1101/2025.02.12.637918.


Effects and mechanisms of APP and its cleavage product Aβ in the comorbidity of sarcopenia and Alzheimer's disease.

Wu J, Tang J, Huang D, Wang Y, Zhou E, Ru Q Front Aging Neurosci. 2024; 16:1482947.

PMID: 39654807 PMC: 11625754. DOI: 10.3389/fnagi.2024.1482947.


Ellagic acid improves the symptoms of early-onset Alzheimer's disease: Behavioral and physiological correlates.

Jha A, Chaube U, Jha A Heliyon. 2024; 10(18):e37372.

PMID: 39309887 PMC: 11416286. DOI: 10.1016/j.heliyon.2024.e37372.


Circadian and sleep phenotypes in a mouse model of Alzheimer's disease characterized by intracellular accumulation of amyloid β oligomers.

Sato T, Ochiishi T, Higo-Yamamoto S, Oishi K Exp Anim. 2023; 73(2):186-192.

PMID: 38092387 PMC: 11091359. DOI: 10.1538/expanim.23-0104.


The Major Hypotheses of Alzheimer's Disease: Related Nanotechnology-Based Approaches for Its Diagnosis and Treatment.

Caceres C, Heusser B, Garnham A, Moczko E Cells. 2023; 12(23).

PMID: 38067098 PMC: 10705786. DOI: 10.3390/cells12232669.


References
1.
Wirths O, Multhaup G, Czech C, Blanchard V, Moussaoui S, Tremp G . Intraneuronal Abeta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice. Neurosci Lett. 2001; 306(1-2):116-20. DOI: 10.1016/s0304-3940(01)01876-6. View

2.
McEwen B, Bowles N, Gray J, Hill M, Hunter R, Karatsoreos I . Mechanisms of stress in the brain. Nat Neurosci. 2015; 18(10):1353-63. PMC: 4933289. DOI: 10.1038/nn.4086. View

3.
McCullough L, Wu L, Haughey N, Liang X, Hand T, Wang Q . Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia. J Neurosci. 2004; 24(1):257-68. PMC: 6729582. DOI: 10.1523/JNEUROSCI.4485-03.2004. View

4.
Billings L, Oddo S, Green K, McGaugh J, LaFerla F . Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron. 2005; 45(5):675-88. DOI: 10.1016/j.neuron.2005.01.040. View

5.
Stella N . Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas. Glia. 2010; 58(9):1017-30. PMC: 2919281. DOI: 10.1002/glia.20983. View